Macrolactin XY, a Macrolactin Antibiotic from Marine-Derived Bacillus subtilis sp. 18.
Ontology highlight
ABSTRACT: Two new compounds, macrolactin XY (1) and (5R, 9S, 10S)-5-(hydroxymethyl)-1,3,7-decatriene-9,10-diol (2), together with nine known compounds (3-11) were isolated from the marine Bacillus subtilis sp. 18 by the OSMAC strategy. These compounds were evaluated for antibacterial activity against six tested microorganisms. Compounds 1-5 and 7-10 showed varied antibacterial activity, with the minimum inhibitory concentration (MIC) ranging from 3 to 12 μg/mL. Macrolactin XY (1) was found to possess superior antibacterial activity, especially exhibiting significant effectiveness against Enterococcus faecalis. The antibacterial activity mechanism against E. faecalis was investigated. The mechanis
SUBMITTER: Xu Y
PROVIDER: S-EPMC11355411 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA